DavidOmbengiPharmD, MBA, MPH

Ambulatory Care Pharmacy, Pharmacotherapy

Chair and Associate Professor of Pharmacy, Family and Community Medicine, South University

David Ombengi, MPH, MBA is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Duquesne UniversityPharmD, 2003
Tulane University School of Public Health & Tropical MedicineMPH, Public Health
Duquesne University/UPMC Medical CenterAcademic Teaching & Research Fellowship, Cardiology/Ambulatory care and Pharmacoeconomics
University of St. ThomasMaster of Business Administration (MBA), Health Care Management

PubMed

16 citations
Inclisiran: A First-in-Class siRNA Therapy for Lowering Low-Density Lipoprotein Cholesterol.
Essie Samuel, Maya Watford, Ugochukwu O Egolum, David N Ombengi, Hua Ling
The Annals of Pharmacotherapy. 2023-03-01
29 citations
Tafamidis: A First-in-Class Transthyretin Stabilizer for Transthyretin Amyloid Cardiomyopathy:
Jonathan Park, Ugochukwu Egolum, Shanea Parker, Ebony Andrews, David Ombengi
The Annals of Pharmacotherapy. 2020-05-01
3 citations
Extended Duration Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With Peripheral Arterial Disease: A Meta-Analysis.
Hua Ling, Ebony Andrews, David Ombengi, Fang Li
Cardiology Research. 2018-06-06